0000914190-15-000122.txt : 20150228
0000914190-15-000122.hdr.sgml : 20150227
20150227164801
ACCESSION NUMBER: 0000914190-15-000122
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150225
FILED AS OF DATE: 20150227
DATE AS OF CHANGE: 20150227
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiovascular Systems Inc
CENTRAL INDEX KEY: 0001180145
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411698056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 651 CAMPUS DRIVE
CITY: ST. PAUL
STATE: MN
ZIP: 55112
BUSINESS PHONE: 651-259-1600
MAIL ADDRESS:
STREET 1: 651 CAMPUS DRIVE
CITY: ST. PAUL
STATE: MN
ZIP: 55112
FORMER COMPANY:
FORMER CONFORMED NAME: REPLIDYNE INC
DATE OF NAME CHANGE: 20020813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Martin David
CENTRAL INDEX KEY: 0001304318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52082
FILM NUMBER: 15660018
MAIL ADDRESS:
STREET 1: 651 CAMPUS DRIVE
CITY: ST. PAUL
STATE: MN
ZIP: 55112
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-02-25
0001180145
Cardiovascular Systems Inc
CSII
0001304318
Martin David
651 CAMPUS DRIVE
ST. PAUL
MN
55112
1
1
0
0
President and CEO
Common Stock
2015-02-25
4
M
0
20800
8.83
A
392489
D
Common Stock
2015-02-25
4
S
0
20800
37.00
D
371689
D
Common Stock
2015-02-25
4
S
0
2000
37.2397
D
369689
D
Common Stock
2015-02-27
5
G
0
2271
0
D
367418
D
Common Stock
850
I
By child
Common Stock
350
I
By child
Common Stock
850
I
By child
Stock Option (right to buy)
8.83
2015-02-25
4
M
0
20800
0
D
2017-02-14
Common Stock
20800
0
D
Stock Option (right to buy)
7.90
2017-06-11
Common Stock
90580
90580
D
Stock Option (right to buy)
12.15
2017-12-11
Common Stock
234395
234395
D
Stock Option (right to buy)
8.75
2019-03-01
Common Stock
32350
32350
D
The shares were sold pursuant to a Rule 10b5-1 trading plan.
Sale of shares to provide funds to satisfy certain tax obligations of the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.155 to $37.3243 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Fully exercisable.
/s/ Amanda Schmall as Attorney-in-Fact for David L. Martin pursuant to Power of Attorney previously filed.
2015-02-27